| Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation D Wrapp, N Wang, KS Corbett, JA Goldsmith, CL Hsieh, O Abiona, ... Science 367 (6483), 1260-1263, 2020 | 9679 | 2020 |
| An mRNA vaccine against SARS-CoV-2—preliminary report LA Jackson, EJ Anderson, NG Rouphael, PC Roberts, M Makhene, ... New England journal of medicine 383 (20), 1920-1931, 2020 | 3447 | 2020 |
| Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ... New England Journal of Medicine 383 (25), 2427-2438, 2020 | 1596 | 2020 |
| SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness KS Corbett, DK Edwards, SR Leist, OM Abiona, S Boyoglu-Barnum, ... Nature 586 (7830), 567-571, 2020 | 1424 | 2020 |
| Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates KS Corbett, B Flynn, KE Foulds, JR Francica, S Boyoglu-Barnum, ... New England Journal of Medicine 383 (16), 1544-1555, 2020 | 1141 | 2020 |
| Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen J Pallesen, N Wang, KS Corbett, D Wrapp, RN Kirchdoerfer, HL Turner, ... Proceedings of the National Academy of Sciences 114 (35), E7348-E7357, 2017 | 1053 | 2017 |
| Pre-fusion structure of a human coronavirus spike protein RN Kirchdoerfer, CA Cottrell, N Wang, J Pallesen, HM Yassine, HL Turner, ... Nature 531 (7592), 118-121, 2016 | 808 | 2016 |
| Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies D Wrapp, D De Vlieger, KS Corbett, GM Torres, N Wang, W Van Breedam, ... Cell 181 (5), 1004-1015. e15, 2020 | 623 | 2020 |
| Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 516 | 2021 |
| Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis RN Kirchdoerfer, N Wang, J Pallesen, D Wrapp, HL Turner, CA Cottrell, ... Scientific reports 8 (1), 15701, 2018 | 510 | 2018 |
| Serum neutralizing activity elicited by mRNA-1273 vaccine K Wu, AP Werner, M Koch, A Choi, E Narayanan, GBE Stewart-Jones, ... New England Journal of Medicine 384 (15), 1468-1470, 2021 | 473 | 2021 |
| mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants K Wu, AP Werner, JI Moliva, M Koch, A Choi, GBE Stewart-Jones, ... BioRxiv, 2021.01. 25.427948, 2021 | 438 | 2021 |
| The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates BE Jones, PL Brown-Augsburger, KS Corbett, K Westendorf, J Davies, ... Science translational medicine 13 (593), eabf1906, 2021 | 389 | 2021 |
| LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants K Westendorf, S Žentelis, L Wang, D Foster, P Vaillancourt, M Wiggin, ... Cell reports 39 (7), 2022 | 343 | 2022 |
| Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates KS Corbett, MC Nason, B Flach, M Gagne, S O’Connell, TS Johnston, ... Science 373 (6561), eabj0299, 2021 | 242 | 2021 |
| mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron M Gagne, JI Moliva, KE Foulds, SF Andrew, BJ Flynn, AP Werner, ... Cell 185 (9), 1556-1571. e18, 2022 | 210* | 2022 |
| Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants L Wang, T Zhou, Y Zhang, ES Yang, CA Schramm, W Shi, A Pegu, ... Science 373 (6556), eabh1766, 2021 | 189 | 2021 |
| Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses J Hicks, C Klumpp-Thomas, H Kalish, A Shunmugavel, J Mehalko, ... Journal of clinical immunology 41, 906-913, 2021 | 176 | 2021 |
| Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid … L Wang, W Shi, JD Chappell, MG Joyce, Y Zhang, M Kanekiyo, ... Journal of virology 92 (10), 10.1128/jvi. 02002-17, 2018 | 170 | 2018 |
| LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection BE Jones, PL Brown-Augsburger, KS Corbett, K Westendorf, J Davies, ... BioRxiv, 2020.09. 30.318972, 2020 | 150 | 2020 |
